順博合金(002996.SZ):擬投2000萬元認購產業投資基金
格隆匯10月13日丨順博合金(002996.SZ)公佈,為了抓住國內新材料行業發展的機遇,進一步實現產業協同,推進產業與資本的有效融合,加強與客户良好合作關係,依託基金管理人的行業經驗、管理和資源優勢,拓展投資渠道,尋找新的利潤增長點,提升公司綜合競爭能力。公司或全資子公司重慶順博兩江金屬材料研究院有限公司(“兩江順博”)擬投資2000萬元,與廣東温氏投資有限公司及其關聯人、廣東新州投資合夥企業(有限合夥)共同參與温潤(珠海)新材料產業投資基金合夥企業(有限合夥)(“温潤新材料”)的管理。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.